Krishnan Rajesh 4
4 · Oncternal Therapeutics, Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Krishnan Rajesh
Chief Technology Officer
Transactions
- Tax Payment
Common Stock
2023-07-03$0.36/sh−10,897$3,923→ 55,857 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.